Literature DB >> 25572240

Polymorphisms of interleukin-31 are associated with anti-CCP levels in females with rheumatoid arthritis.

Ji-In Yu1, Young-Ran Park, Shin-Seok Lee, Soo-Cheon Chae.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25572240     DOI： 10.1007/s12041-014-0423-7

Source DB:  PubMed          Journal:  J Genet        ISSN： 0022-1333            Impact factor:   1.166


× No keyword cloud information.
  23 in total

1.  Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies.

Authors:  D Baeten; I Peene; A Union; L Meheus; M Sebbag; G Serre; E M Veys; F De Keyser
Journal:  Arthritis Rheum       Date:  2001-10

2.  Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing population.

Authors:  Cheng-Che E Lan; Hung-Pin Tu; Ching-Shuang Wu; Ying-Chin Ko; Hsin-Su Yu; Yi-Wei Lu; Wan-Chen Li; Yin-Chun Chen; Gwo-Shing Chen
Journal:  Exp Dermatol       Date:  2011-10-20       Impact factor: 3.960

3.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Authors:  G A Schellekens; H Visser; B A de Jong; F H van den Hoogen; J M Hazes; F C Breedveld; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-01

4.  Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis.

Authors:  C C Reparon-Schuijt; W J van Esch; C van Kooten; G A Schellekens; B A de Jong; W J van Venrooij; F C Breedveld; C L Verweij
Journal:  Arthritis Rheum       Date:  2001-01

5.  Is it possible to predict the first year extent of pain and disability for patients with rheumatoid arthritis?

Authors:  A van der Heide; J W Jacobs; H C Haanen; J W Bijlsma
Journal:  J Rheumatol       Date:  1995-08       Impact factor: 4.666

6.  Association of TBX21 polymorphisms in a Korean population with rheumatoid arthritis.

Authors:  Soo Cheon Chae; Seung Cheol Shim; Hun Taeg Chung
Journal:  Exp Mol Med       Date:  2009-01-31       Impact factor: 8.718

7.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.

Authors:  Stacey R Dillon; Cindy Sprecher; Angela Hammond; Janine Bilsborough; Maryland Rosenfeld-Franklin; Scott R Presnell; Harald S Haugen; Mark Maurer; Brandon Harder; Janet Johnston; Susan Bort; Sherri Mudri; Joseph L Kuijper; Tom Bukowski; Pamela Shea; Dennis L Dong; Maria Dasovich; Francis J Grant; Luann Lockwood; Steven D Levin; Cosette LeCiel; Kim Waggie; Heather Day; Stavros Topouzis; Janet Kramer; Rolf Kuestner; Zhi Chen; Don Foster; Julia Parrish-Novak; Jane A Gross
Journal:  Nat Immunol       Date:  2004-06-06       Impact factor: 25.606

8.  A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema.

Authors:  Florian Schulz; Ingo Marenholz; Regina Fölster-Holst; Christiane Chen; Alexander Sternjak; Ria Baumgrass; Jorge Esparza-Gordillo; Christoph Grüber; Renate Nickel; Stefan Schreiber; Monika Stoll; Michael Kurek; Franz Rüschendorf; Norbert Hubner; Ulrich Wahn; Young-Ae Lee
Journal:  J Allergy Clin Immunol       Date:  2007-09-27       Impact factor: 10.793

9.  Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: implications for the allergic response.

Authors:  Wai K Ip; Chun K Wong; Mandy L Y Li; Pok W Li; Phyllis F Y Cheung; Christopher W K Lam
Journal:  Immunology       Date:  2007-07-11       Impact factor: 7.397

Review 10.  Genetics of rheumatoid arthritis: confronting complexity.

Authors:  P K Gregersen
Journal:  Arthritis Res       Date:  1999-10-26
View more
  1 in total

1.  Diagnostic value of high-frequency color Doppler ultrasonography examination in combination with anti-cyclic citrullinated peptide antibody testing in rheumatoid arthritis patients.

Authors:  Ming-Yu Wang; Xian-Bin Wang; Xue-Hui Sun; Feng-Li Liu; Sheng-Chuan Huang
Journal:  Exp Ther Med       Date:  2017-01-17       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.